ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Validating Value Data: AI & Outcomes
The application of AI and machine learning in establishing a treatment’s value proposition is still a relatively new concept in pharma. Learn more in this article.
Patient Voices in the Industry
Will Maier and Kelly Franchetti discuss orphan drugs and patients' role in clinical trials as demand in the market increases.
Patient-Centric Approach to Improve the Patient Experience
Joyce Moore, Director Patient Recruitment Services, discusses the changing dynamics of the patient journey in engaging potential patients.
The Blockchain Movement
Ronan Fox, VP, Applied Digital Solutions discusses blockchain in clinical trials, particularly as an enabler of virtual trials.
Ioannis Katsoulis, Axel Svedbom, Larushka Mellor and Örjan Åkerborg consider trends and strategies to drive uptake of biosimilars in the UK.
The Path to Successful HTA Submissions
Manpreet Sidhu discusses the factors that are key to success in achieving favourable HTA reviews around the world in this Pharmafocus article.
Assessing The Impact Of MDR & IVDR On Patients
This article explores the need to assess the impact of MDR/IVDR on patients after the new medical device regulation is established.
Standardized eCOA Questionnaire Library Will Speed Study Start-Up
Read about ICON’s Mapi Research Trust & Medidata's plan to develop a global library of pre-configured, pre-approved eCOA questionnaires to accelerate study start-up.
Shock to the System: An Examination of Neurostim Technologies
Learn how targeted electrical nerve stimulation technology can aid in chronic disease management by improving on current treatment methods.
Tom O'Leary considers how the Internet of Medical Things (loMT) is evolving the patient role in pharma.